NCI study finds people with SARS-CoV-2 antibodies may have low risk of future infection

https://www.eurekalert.org/pub_releases/2021-02/nci-nsf021921.php

 

News Release 24-Feb-2021
NIH/National Cancer Institute

 

People who have had evidence of a prior infection with SARS-CoV-2, the virus that causes COVID-19, appear to be well protected against being reinfected with the virus, at least for a few months, according to a newly published study from the National Cancer Institute (NCI). This finding may explain why reinfection appears to be relatively rare, and it could have important public health implications, including decisions about returning to physical workplaces, school attendance, the prioritization of vaccine distribution, and other activities.


•••••